} ?>
Shanghai Composite Index: 3052.90+0.27% 315.798 billion Yuan
Shenzhen Composite Index: 9264.48+0.14% 458.498 billion yuan
IF0:3533.40+0.37%
HSI: 17284.54+0.48%
Dow Jones: 38460.92 0.00%
NASDAQ: 15712.75 0.00%
Stoke 50:4913.55 -1.53%
FTSE UK 100:8047.75+0.09%
Nikkei: 37628.48 -2.16%
NYMEX Crude Oil: 82.93+0.15%
COMEX Gold: 2329.45 -0.38%
COMEX Silver: 27.25 -0.34%
LME Copper: 9916.15+1.46%
Recent Visits
Name Price (CNY)
The following are the hot stocks
4.72 0.00%
4.32 0.93%
4.84 0.00%
11.33 1.61%
38.95 0.21%
208.94 0.73%
41.06 1.13%
1693.04 -0.03%
11.69 0.34%
28.54 3.14%
12.35 -0.80%
9.85 -1.30%
To view your stock selection, please log in first
Name Price (CNY)
Add Reminder
huaxi biology (688363.SH) ask shares
0.59
+1.01%
58.77
Limit: 69.82
Limit: 46.54
Suspension
2024-04-25 15:00:00
Temporary suspension
Open today: | 58.10 | Volume: | 12700 Hands | Amplitude: | 2.29% |
---|---|---|---|---|---|
Highest: | 59.18 | Turnover: | 74.5991 million yuan | Exchange rate: | 0.64% |
Minimum: | 57.85 | Total Market Capitalization: | 28.308 billion | Price-to-Book Ratio: | 4.09 |
Yesterday: | 58.18 | Circulation value: | 11.647 billion | P/E TTM: | 35.04 |
Total equity: | 0.482 billion | Shares outstanding: | 0.198 billion |
Issued share capital: 49.5626 million Registered capital: 0.482 billion Same share and same right: yes
other industries +0.31 leading shares: vinegar shares 12.76+10.00
Timeshare
Day K
Week K
Month K
K line
Re-weighted K line
Technical diagram
Time-sharing 5-day year line
No reinstatement
Previous reinstatement
Post-reinstatement
B/S point day K
No reinstatement
Previous reinstatement
Post-reinstatement
Week K
No reinstatement
Previous reinstatement
Post-reinstatement
Month K
No reinstatement
Previous reinstatement
Post-reinstatement
Year K
No reinstatement
Previous reinstatement
Post-reinstatement
5 points
15 min 30 min 60 min
2024/04/25/4 15:00 price 58.77 58.78 110 1.01%
▲ ▼ No quantitative ratio MACDBOLLRSIBBIBOLL
Trend comparison:
At the same time:
Aimei Ke (293.18 1.85% Join Trend Comparison)
Tiger Medicine (53.01 0.78% Added Trend Comparison)
kailaiying (76.86 -0.59 added trend comparison)
kang long into a (18.24 0.39 added trend comparison)
beitani (57.51 -0.95 added trend comparison)
Cobos (42.40 1.44% added trend comparison)
haohai biological department (92.62 -0.37 joining trend comparison)
stone technology (373.79 -2.81 added trend comparison)
medisi (32.69 0.71% added trend comparison)
Five-gear plate opening
Master Live
Commission ratio 67.63% 241 | ||
---|---|---|
Sell ⑤ | 58.87 | 8 |
Sell ④ | 58.85 | 7 |
Sell ③ | 58.84 | 2 |
Sell ② | 58.83 | 28 |
Sell ① | 58.82 | 13 |
Done | 58.77 | |
Buy ① | 58.77 | 196 |
Buy ② | 58.72 | 4 |
Buy ③ | 58.68 | 54 |
Buy ④ | 58.67 | 2 |
Buy ⑤ | 58.66 | 43 |
there is a key big order, the main force or in **
Timeshare
Time | Price (Yuan) | quantity (hand) | Properties |
---|---|---|---|
15:00:00 | 58.77 | 110 | neutral disk |
14:56:55 | 58.66 | 4 | sell |
14:56:52 | 58.66 | 2 | sell |
14:56:40 | 58.72 | 6 | sell |
14:56:31 | 58.82 | 14 | Buy |
14:56:22 | 58.82 | 4 | Buy |
14:56:19 | 58.73 | 7 | sell |
14:56:13 | 58.82 | 3 | Buy |
14:56:10 | 58.82 | 2 | Buy |
14:56:07 | 58.79 | 10 | neutral disk |
14:56:04 | 58.80 | 4 | sell |
Scan code subscription
Investment Report
retail sell retail buy main sell main buy
main buy main sell retail buy retail sell
Amount ($million) 1352.92 1021.16 2144.85 2474.09
proportion 18.13% 13.69% 28.75% 33.16% bulk single small single large single extra large single
loose orders, small orders, large orders, large orders, large orders
Net inflow ($million) 137.42 -466.66 88.72 243.04
0.17% 0.26% 0.20% 0.02%
25.87% 40.00% 30.87% 3.26%
feichao new material IPO: research and development costs continue to surge "step on the line to meet the standards" customer related parties through private placement low price surprise stake in scientific research attribute
2024-04-23 16:10:51
Product: Sina Finance Listed Company Research Institute Author: IPO Refinancing Group/Zheng Quan Recently, the CSRC intends to revise the evaluation index of the science and technology attributes, aiming to adhere to the functional positioning of the plate, highlight the "hard technology" characteristics of the science and technology board, and strengthen the requirements of the science and technology attributes. There are three main contents to be revised in the draft of the "Guidelines for the Evaluation of the Attributes of Science and Technology Innovation (Trial)". One is that the last three years...
Keming Foods lowers the amount of funds raised to help the real controller? The main business is lost and the real controller's family's pig farming assets are "thunderstorms"
2024-04-11 17:51:12
Produced by: Sina Finance Listed Company Research Institute Author: Langtou Diet/Hao Xian Recently, as the share price fell sharply, Keming Foods significantly reduced the number of fixed issuance. In the case of the stock price and the issue price upside down for the real controller family "out of the way". Since mid-January this year, Keming Food's share price has fallen by nearly 20%, and its current valuation is only 1.09 times PB. The company...
the amount of venture capital in March fell by more than 40% year-on-year: Dalian Wanda business management was invested in 60 billion CDH's first real estate fund
2024-04-09 17:52:36
Production: Edited by Sina Finance Listed Company Research Institute: shu China's private equity investment market ushered in the largest single investment in the past five years. According to public reports, on March 30, Dalian Wanda Business Management and PAG Pacific Alliance Group, Ares Management, and Invest, Abu Dhabi sovereign wealth fund Mubadala, UAE...
Zhongxin Airlines net profit halved radical expansion consequences show that the main customer sales collective weak market share or will continue to decline
2024-04-09 17:52:36
Production: Sina Finance Listed Company Research Institute Author: Hao Recently, Zhongchong Xinhang released its annual report showing that in 2023, the company achieved operating income of 27.006 billion yuan, up 32.5 percent year-on-year, and net profit of 0.294 billion yuan, down 57.44 percent year-on-year. In contrast, Ningde's revenue and net profit growth during the same period were 22% and 44%, respectively. phase...
feichao new material IPO: research and development costs continue to surge "step on the line to meet the standards" customer related parties through private placement low price surprise stake in scientific research attribute
2024-04-23 16:10:51
Product: Sina Finance Listed Company Research Institute Author: IPO Refinancing Group/Zheng Quan Recently, the CSRC intends to revise the evaluation index of the science and technology attributes, aiming to adhere to the functional positioning of the plate, highlight the "hard technology" characteristics of the science and technology board, and strengthen the requirements of the science and technology attributes. There are three main contents to be revised in the draft of the "Guidelines for the Evaluation of the Attributes of Science and Technology Innovation (Trial)". One is that the last three years...
Keming Foods lowers the amount of funds raised to help the real controller? The main business is lost and the real controller's family's pig farming assets are "thunderstorms"
2024-04-11 17:51:12
Produced by: Sina Finance Listed Company Research Institute Author: Langtou Diet/Hao Xian Recently, as the share price fell sharply, Keming Foods significantly reduced the number of fixed issuance. In the case of the stock price and the issue price upside down for the real controller family "out of the way". Since mid-January this year, Keming Food's share price has fallen by nearly 20%, and its current valuation is only 1.09 times PB. The company...
the amount of venture capital in March fell by more than 40% year-on-year: Dalian Wanda business management was invested in 60 billion CDH's first real estate fund
2024-04-09 17:52:36
Production: Edited by Sina Finance Listed Company Research Institute: shu China's private equity investment market ushered in the largest single investment in the past five years. According to public reports, on March 30, Dalian Wanda Business Management and PAG Pacific Alliance Group, Ares Management, and Invest, Abu Dhabi sovereign wealth fund Mubadala, UAE...
Zhongxin Airlines net profit halved radical expansion consequences show that the main customer sales collective weak market share or will continue to decline
2024-04-09 17:52:36
Production: Sina Finance Listed Company Research Institute Author: Hao Recently, Zhongchong Xinhang released its annual report showing that in 2023, the company achieved operating income of 27.006 billion yuan, up 32.5 percent year-on-year, and net profit of 0.294 billion yuan, down 57.44 percent year-on-year. In contrast, Ningde's revenue and net profit growth during the same period were 22% and 44%, respectively. phase...
Follow the public number to view the full text
Corporate Capital
Sweep and pay attention to me
Company Research
hot data more main business income (billion yuan)
Adjacent rank
Top 10
2023-09 huaxi biological main business income (billion yuan) industry ranked first (4)
Huaxi Bio Meike * ST Meigu Jinbo Bio 01020304050
Financial Ratios More ROE
Adjacent rank
Top 10
2023-09 huaxi biological return on net assets industry ranked 3rd (4th)
Jin Bo Biology Aimei Ke Hua Xi Biology * ST Mei Gu 0612182430
Research Agency Investment Rating More
66 research reports have issued Huaxi Biological (sh688363) ratings in the last 60 days, and the comprehensive ratings are as follows:
Hotspot
Industry Comparison Increase
Name price (yuan) increase (%)
12.76 10.00
12.57 3.63
9.37 3.42
4.29 3.37
2.85 3.26
9.76 3.06
36.09 2.85
7.93 2.59
Company Name:
Huaxi Biotechnology Co., Ltd.
Main Business:
Microbial fermentation and cross-linking two major technology platforms, the development of biological activities that contribute to human life and health...
Tel:0531-82685888
Fax:0531-82685888
Date of Establishment:2000-01-03
Listing Date:2019-11-06
Legal Representative: Zhao Yan
General Manager: Zhao Yan
Registered capital: 481.678 million yuan
Issue price:47.790 yuan
Latest total share capital: 481.678242 million shares
Latest shares outstanding: 10,000 shares
2023-09
2023-06
2023-03
2022-12
2022-09
EPS | 1.0679 yuan | 0.8815 yuan | 0.4164 yuan | 2.0182 yuan | 1.4081 yuan |
---|---|---|---|---|---|
Net assets per share | 14.3795 yuan | 14.2341 yuan | 14.2957 yuan | 13.7892 yuan | 13.0915 yuan |
Net operating cash flow per share | 0.4876 yuan | 0.3870 yuan | -0.4119 yuan | 1.3203 yuan | 0.2421 yuan |
ROE | 7.43% | 6.19% | 2.91% | 14.64% | 10.76% |
Undistributed profit per share | 4.9194 yuan | 4.7458 yuan | 4.8920 yuan | 4.4798 yuan | 3.8697 yuan |
Capitalization per share | 7.9533 yuan | 7.9381 yuan | 7.8967 yuan | 7.8008 yuan | 7.7614 yuan |
Announcement Date | Allocation Scheme |
---|---|
2023-06-15 | 10 6.1 yuan |
2022-05-10 | 10 4.9 yuan |
2021-07-09 | 10 4.1 yuan |
2020-07-11 | 10 3.7 yuan |
2023-09
2023-08
2023-06
Name of shareholder | Ownership (%) | Increase or decrease |
---|---|---|
Guoshou Chengda (Shanghai... | 17.375 | Unchanged |
China Merchants Bank shares have... | 10.113 | Overweight |
Beijing Guoshou Taihe Phase I... | 2.940 | Unchanged |
Tianjin huajie haihe medical... | 2.725 | Unchanged |
Industrial and Commercial Bank of China Stock... | 2.634 | Overweight |
WEST SU... | 2.526 | Unchanged |
Hong Kong Securities Clearing Company Limited has... | 2.482 | Reduce |
bank of China shares have... | 1.554 | Reduce |
Fortune... | 1.508 | Unchanged |
Ariz (Tianjin)... | 1.408 | Unchanged |
Shareholder Name Shareholding (%) Increase or decrease
Guoshou Chengda (Shanghai... 17.375 unchanged
China Merchants Bank shares have... 9.563 increase
Beijing Tonghui Taihe Investment... 2.940 unchanged
Tianjin Huajie Haihe Medical... 2.725 unchanged
Hong Kong Central Clearing has... 2.620 to increase its holdings
WEST SU... 2.526 unchanged
Industrial and Commercial Bank of China shares... 2.517 increase
Bank of China shares have... 1.651 increase
Fortune... 1.508 unchanged
Ariz (Tianjin)... 1.408 unchanged
Shareholder Name Shareholding (%) Increase or decrease
Guoshou Chengda (Shanghai... 17.375 unchanged
China Merchants Bank shares have... 5.869 increase
Beijing Tonghui Taihe Investment... 2.940 New
Tianjin Huajie Haihe Medical... 2.725 Unchanged
Hong Kong Central Clearing has... 2.604 reduction
WEST SU... 2.526 unchanged
Industrial and Commercial Bank of China shares... 1.951 new
Bank of China shares have... 1.589 increase
Fortune... 1.508 unchanged
Ariz (Tianjin)... 1.408 unchanged
Shareholding ratio of outstanding shareholders
Customer service hotline: 4000520066 welcome criticism and correction
frequently asked questions and answers internet illegal and bad information reporting sina financial feedback message board
Sina profile About Sina advertising service contact us recruitment information website lawyer SINA English pass registration product answer
Sina Corporation Copyright Sina Finance provides free stock, fund, bond, foreign exchange and other market data and other materials from relevant partners, only for the purpose of obtaining information for users, and does not constitute investment advice.
Sina Finance and its partners are not responsible for errors, inaccuracies, delays in providing information on this page or for any actions taken in reliance on this information. The market is risky and investment needs to be cautious.
Ticker Name
Percentage Change
Inclusion Date